Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00619450 · ClinicalTrials.gov registry record

Siemens 3-D C-Arm CT of the Heart Chambers

A clinical trial of Atrial Fibrillation, sponsored by The Cleveland Clinic.

Completed
Registry status
16
Enrollment target
1
Study location

NCT00619450: Completed study of Atrial Fibrillation, sponsored by The Cleveland Clinic.

NCT00619450 is a study of Atrial Fibrillation that has completed, run by The Cleveland Clinic. The registered enrollment target is 16 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00619450, a study of Atrial Fibrillation, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
16 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the optimal images of the heart structures which are used to guide AF ablation or BiVenticle and coronary vessels.

Conditions Studied

Interventions

  • OTHER 3D C-arm CT scan

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2007-08
Est. Completion 2008-09
The Cleveland Clinic

688 total trials

What the finished NCT00619450 record still lists

NCT00619450 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which 3D C-arm CT scan is the first listed.

NCT00619450 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT00619450 about?

NCT00619450 is a clinical study titled "Siemens 3-D C-Arm CT of the Heart Chambers". The purpose of this study is to determine the optimal images of the heart structures which are used to guide AF ablation or BiVenticle and coronary vessels.

What is the current status of trial NCT00619450?

This trial is currently completed. The enrollment target is 16 participants. The study started on 2007-08. Estimated completion is 2008-09.

What conditions does trial NCT00619450 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT00619450?

The interventions under investigation include: 3D C-arm CT scan (OTHER).

Who is sponsoring clinical trial NCT00619450?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00619450 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00619450's enrollment target sits among peer trials

16 197th of 202 higher than 6 of 202 other Atrial Fibrillation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00619450, the US trial registry maintained by the National Library of Medicine. NCT00619450 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.